Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 1439901-97-9
2. Ono-4059 Hydrochloride
3. Tirabrutinib Hcl
4. Gs-4059 Hydrochloride
5. Ono-4059(hcl Salt)
6. Ono-4059 (hydrochloride)
7. U374135n48
8. Tirabrutinib (hydrochloride)
9. 6-amino-9-[(3r)-1-but-2-ynoylpyrrolidin-3-yl]-7-(4-phenoxyphenyl)purin-8-one;hydrochloride
10. Tirabrutinib Hydrochloride (jan)
11. Tirabrutinib Hydrochloride [jan]
12. (r)-6-amino-9-(1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7h-purin-8(9h)-one Hydrochloride
13. Velexbru (tn)
14. Ono-4059 (gs-4059) Hydrochloride
15. Ono4059 Hydrochloride
16. Gs-4059 (hydrochloride)
17. Ono-4059 Hcl
18. Schembl16143622
19. Unii-u374135n48
20. Ex-a1275
21. Hy-15771a
22. Mfcd30187521
23. S8166
24. Akos030526538
25. Ccg-269621
26. Cs-5637
27. Ac-35380
28. Tirabrutinib Hydrochloride [who-dd]
29. D11070
30. F10061
31. A901181
32. Q27290633
33. (r)-6-amino-9-(1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7,9-dihydro-8h-purin-8-one Hydrochloride;ono-4059 Hydrochloride
34. (r)-6-amino-9-(1-but-2-ynoylpyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7h-purin-8(9h)-one Hcl Salt
| Molecular Weight | 490.9 g/mol |
|---|---|
| Molecular Formula | C25H23ClN6O3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 4 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 105 |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 825 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
ABOUT THIS PAGE
A Tirabrutinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tirabrutinib Hydrochloride, including repackagers and relabelers. The FDA regulates Tirabrutinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tirabrutinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tirabrutinib Hydrochloride supplier is an individual or a company that provides Tirabrutinib Hydrochloride active pharmaceutical ingredient (API) or Tirabrutinib Hydrochloride finished formulations upon request. The Tirabrutinib Hydrochloride suppliers may include Tirabrutinib Hydrochloride API manufacturers, exporters, distributors and traders.
Tirabrutinib Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tirabrutinib Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tirabrutinib Hydrochloride GMP manufacturer or Tirabrutinib Hydrochloride GMP API supplier for your needs.
A Tirabrutinib Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Tirabrutinib Hydrochloride's compliance with Tirabrutinib Hydrochloride specifications and serves as a tool for batch-level quality control.
Tirabrutinib Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Tirabrutinib Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tirabrutinib Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Tirabrutinib Hydrochloride EP), Tirabrutinib Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tirabrutinib Hydrochloride USP).
LOOKING FOR A SUPPLIER?
